Search

Displaying results 2391 - 2400 of 7063 in total
  1. Drug

    1-Palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol))

    go.drugbank.com/drugs/DB11331
    ApprovedWithdrawn

    Palmitoyloleoyl-phosphatidylglycerol was a component of Surfaxin, discontinued in 2017, which acted as a surfactant [FDA Label].

  2. Drug

    Bleomycin

    go.drugbank.com/drugs/DB00290
    ApprovedInvestigational

    It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. Bleomycin A2 is used as the representative structure for Bleomycin. … A complex of related glycopeptide antibiotics from <i>Streptomyces verticillus</i> consisting of bleomycin A2 and B2 (B2 CAS # 9060-10-0).

  3. Drug

    Velpatasvir

    go.drugbank.com/drugs/DB11613
    ApprovedInvestigational

    Velpatasvir is a Direct-Acting Antiviral (DAA) medication used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). … Velpatasvir acts as a defective substrate for NS5A (Non-Structural Protein 5A), a non-enzymatic viral protein that plays a key role in Hepatitis C Virus replication, assembly, and modulation of host immune

  4. Drug

    Phenelzine

    go.drugbank.com/drugs/DB00780
    ApprovedInvestigational

    [A15753] It was developed by Parke Davis and originally FDA approved on June 9th, 1961. It is currently approved under prescription by the name of Nardil. … Phenelzine, with the formula β-phenylethylhydrazine, is a monoamine oxidase inhibiting antidepressant that is effective in the treatment of panic disorder and social anxiety disorder.

    Categories: Monoamine Oxidase A Substrates
  5. Drug

    Interferon alfa-n3

    go.drugbank.com/drugs/DB00018
    Approved

    Purified, natural (n is for natural) human interferon alpha proteins (consists of 3 forms or polymorphisms including 2a, 2b and 2c). 166 residues, some are glycosylated (MW range from 16 kD to 27 kD).

  6. Drug

    Limnetrelvir

    go.drugbank.com/drugs/DB21677
    Experimental

    Limnetrelvir has a monoisotopic molecular weight of 557.17 Da. … Limnetrelvir is a small molecule drug. The usage of the INN stem '-trelvir' in the name indicates that Limnetrelvir is a antiviral 3CL protease inhibitor.

  7. Drug

    Epsametostat

    go.drugbank.com/drugs/DB21726
    Experimental

    Epsametostat has a monoisotopic molecular weight of 611.28 Da. … Epsametostat is a small molecule drug. The usage of the INN stem '-metostat' in the name indicates that Epsametostat is a histone N-methyltransferase inhibitor.

  8. Drug

    Enerisant

    go.drugbank.com/drugs/DB20605
    Experimental

    Enerisant has a monoisotopic molecular weight of 398.23 Da. … Enerisant is a small molecule drug. The usage of the INN stem '-isant' in the name indicates that Enerisant is a histamine H3​ receptor antagonist.

  9. Drug

    Levolansoprazole

    go.drugbank.com/drugs/DB20673
    Experimental

    Levolansoprazole has a monoisotopic molecular weight of 369.08 Da. … Levolansoprazole is a small molecule drug. The usage of the INN stem '-prazole' in the name indicates that Levolansoprazole is a benzimidazole derivative antiulcer medication.

  10. Drug

    Acorafloxacin

    go.drugbank.com/drugs/DB19496
    Experimental

    Acorafloxacin has a monoisotopic molecular weight of 419.17 Da. … Acorafloxacin is a small molecule drug. The usage of the INN stem '-oxacin' in the name indicates that Acorafloxacin is a nalidixic acid derivative antibacterial.